Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49978,303,1.50 [1.19-1.88],0.00049763340632
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51784,397,1.57 [1.29-1.90],5.560367393033836e-06
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",51253,2798,1.30 [1.20-1.41],4.596011972773807e-11
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Candidiasis,51825,861,1.25 [1.09-1.44],0.0020351749060474
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,50260,7080,1.24 [1.18-1.30],1.261887352949513e-16
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),50452,6456,1.33 [1.27-1.41],9.141536568618674e-28
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,51314,2455,1.22 [1.12-1.33],5.273966116825702e-06
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,51640,174,1.65 [1.24-2.19],0.0006413129691166
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,47701,1970,1.37 [1.25-1.51],1.7862990764274058e-11
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,46072,2229,1.54 [1.42-1.68],1.6006166402999583e-24
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45817,517,1.54 [1.29-1.83],1.230096769419468e-06
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36416,4000,1.30 [1.21-1.39],2.091805425076283e-14
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,45512,789,1.25 [1.08-1.46],0.0035851638165129
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51752,2893,1.23 [1.13-1.33],3.463170139519709e-07
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,51983,1019,1.21 [1.06-1.38],0.0046491800877393
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,50333,1878,1.31 [1.19-1.44],2.772703879135249e-08
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51849,2174,1.35 [1.23-1.47],2.901252599964821e-11
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,49258,399,1.58 [1.30-1.91],3.927173376382865e-06
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,52085,100,1.15 [0.74-1.77],0.5373724271536253
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,51576,1901,1.31 [1.20-1.45],1.4296576231988409e-08
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51620,154,1.30 [0.93-1.82],0.1263123433870644
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51920,316,1.32 [1.05-1.66],0.0193987900010716
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51883,279,1.22 [0.95-1.57],0.1226284841178497
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,49306,851,1.49 [1.30-1.70],5.55070674548389e-09
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,49015,560,1.10 [0.91-1.32],0.3307158347614616
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,49080,221,1.15 [0.86-1.54],0.3484158862083925
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,52042,106,2.02 [1.44-2.84],4.7837353380461486e-05
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51954,304,0.94 [0.73-1.22],0.6604167518815176
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Viral warts,51749,99,1.10 [0.71-1.71],0.6701310787378212
CLSTN2,Calsyntenin-2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],51780,130,0.85 [0.56-1.27],0.4244782579330494
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,51490,593,0.94 [0.78-1.13],0.5172279295869069
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51907,116,0.97 [0.63-1.47],0.8753319388048112
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51869,127,0.89 [0.59-1.35],0.5906934080681647
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23959,131,0.86 [0.57-1.29],0.4625314635470298
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",51415,2901,1.08 [1.00-1.18],0.0498946271743632
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of meninges,52057,115,0.89 [0.58-1.38],0.6127175214072005
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51953,133,1.27 [0.88-1.83],0.2002014149727753
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,52035,215,1.10 [0.82-1.48],0.5355328289131831
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm of ovary,27992,181,1.00 [0.71-1.40],0.9986631179458704
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,52038,729,1.15 [0.98-1.35],0.079681404265533
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Caecum,52040,594,0.98 [0.81-1.18],0.8337582467841731
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51864,149,1.10 [0.77-1.57],0.6029778229185934
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Descending colon,52034,436,1.29 [1.06-1.57],0.0097828785050345
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,51954,714,1.09 [0.93-1.29],0.2941574123139946
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51853,1236,1.10 [0.97-1.25],0.1199258669363404
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,52022,867,1.05 [0.91-1.22],0.4934706599698248
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Carcinoma in situ of breast,22764,139,1.07 [0.73-1.56],0.7244116761225797
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22856,169,1.14 [0.82-1.60],0.4324316025531923
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",41488,104,1.19 [0.78-1.81],0.4251887801326545
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",41525,141,0.91 [0.61-1.34],0.6263155295621105
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51983,240,1.08 [0.82-1.44],0.5763835709612803
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Haemangioma, any site",51984,235,1.11 [0.84-1.48],0.467512046988093
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Leiomyoma of uterus,27067,598,0.90 [0.75-1.09],0.2932446055375957
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Lung cancer and mesothelioma,36120,664,1.08 [0.91-1.28],0.3925885496208684
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Lymphoid leukaemia,41487,103,1.05 [0.67-1.63],0.8382472249233148
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41765,381,1.17 [0.94-1.46],0.1701790823235024
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41794,410,1.15 [0.93-1.42],0.2093309136498275
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22992,190,1.36 [1.01-1.83],0.0439260371823356
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",41546,162,2.56 [2.02-3.26],1.7765185448113282e-14
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",41603,219,1.06 [0.79-1.43],0.7030878681966051
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",41581,197,1.31 [0.98-1.76],0.067090687551081
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22946,144,0.92 [0.63-1.36],0.679422778634547
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",41571,187,1.00 [0.71-1.39],0.9825701883640472
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",20000,1418,0.97 [0.86-1.10],0.6444248481530255
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",41616,232,1.00 [0.74-1.34],0.9761670323930632
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",41534,150,1.20 [0.85-1.70],0.3029540491366111
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,41597,213,0.92 [0.67-1.27],0.6110996923654626
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi,51689,406,1.17 [0.94-1.45],0.1563160361676688
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanocytic naevi of trunk,52004,176,1.45 [1.07-1.95],0.0160262620739952
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Melanoma in situ,41452,164,0.81 [0.56-1.18],0.2779596083798216
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",41569,185,0.93 [0.66-1.30],0.6646799422903613
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41710,326,1.00 [0.78-1.29],0.9976442839736268
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41836,452,0.94 [0.76-1.16],0.5450437769114838
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",41584,200,0.90 [0.65-1.25],0.5286254980395462
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,Other benign neoplasms of skin,51719,311,0.79 [0.61-1.04],0.0924896666281828
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",43560,2176,1.01 [0.92-1.12],0.8076036241320897
CLSTN2,Calsyntenin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",43679,2295,1.03 [0.94-1.13],0.5183987312543187
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,51497,691,1.08 [0.91-1.27],0.395002992120369
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,48262,223,1.91 [1.50-2.42],9.706570940904194e-08
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50949,143,1.90 [1.42-2.54],1.5011179628938832e-05
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,50476,5839,1.26 [1.19-1.33],5.261174633521621e-16
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,49115,98,1.75 [1.21-2.55],0.0032874964401461
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,51242,99,1.42 [0.94-2.12],0.0923298388008454
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,51100,3061,1.30 [1.21-1.40],8.580374408154976e-12
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,51098,3059,1.30 [1.21-1.40],7.311171677255001e-12
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,48215,176,1.61 [1.21-2.16],0.0012441867088992
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,51422,2405,1.37 [1.26-1.49],1.869373016520323e-13
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,51370,227,1.53 [1.18-1.98],0.001322191178232
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,50933,127,1.49 [1.06-2.09],0.022985924074052
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50925,119,1.21 [0.82-1.79],0.3447079736039181
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,51699,556,1.73 [1.48-2.02],4.262160329550589e-12
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51872,110,0.87 [0.56-1.35],0.533313108779884
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",51604,461,1.81 [1.53-2.14],2.782282383356336e-12
CLSTN2,Calsyntenin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,49233,216,1.02 [0.75-1.38],0.907283279537879
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,40307,640,1.81 [1.57-2.08],5.61212766698209e-16
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,48572,236,1.14 [0.84-1.53],0.4010833089423533
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,48594,258,1.98 [1.62-2.43],3.452964838579224e-11
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39778,111,1.47 [1.01-2.15],0.0464591626199699
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,48356,137,0.99 [0.68-1.46],0.9789279703471888
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,47213,480,1.08 [0.88-1.32],0.4503589239788175
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",51134,1144,1.27 [1.12-1.44],0.0002266616614641
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,50523,533,1.19 [0.98-1.44],0.0715729220302751
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,50247,257,1.00 [0.76-1.33],0.9833236650786176
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,51365,3146,0.92 [0.85-1.00],0.0422443919159706
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,45377,3051,0.93 [0.86-1.01],0.0832516386511722
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39802,135,1.09 [0.74-1.59],0.6668990707940468
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",48020,160,0.98 [0.68-1.40],0.8948085608385868
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,40232,565,1.21 [1.01-1.45],0.0374297072226648
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39788,121,1.56 [1.10-2.21],0.0133029184769685
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46794,7127,1.01 [0.96-1.06],0.7466003720926178
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,40057,390,1.45 [1.18-1.78],0.000354239262587
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40784,1117,1.31 [1.16-1.49],1.875633003240488e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51919,658,1.09 [0.91-1.29],0.3485505359790732
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,51539,278,1.06 [0.82-1.38],0.6473184254051128
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39924,257,1.38 [1.07-1.78],0.0127887780668683
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39789,122,1.68 [1.20-2.36],0.0026065298930822
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50993,3133,0.99 [0.91-1.07],0.8212246489187335
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,40184,517,1.89 [1.62-2.20],7.791449312975362e-16
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,40270,603,1.73 [1.49-2.01],7.927004199374337e-13
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40946,1279,1.11 [0.98-1.25],0.1051920329198187
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39907,240,1.30 [1.00-1.71],0.0529820103399714
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,51522,261,1.08 [0.82-1.41],0.5923977521541272
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40879,1212,1.28 [1.13-1.45],6.654282109889893e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40636,969,1.24 [1.08-1.42],0.0019049488689156
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46875,142,1.55 [1.11-2.16],0.0095785692086412
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49705,10038,1.08 [1.03-1.13],0.0007006461092554
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47959,99,1.13 [0.73-1.76],0.5827121789781078
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47971,111,1.01 [0.66-1.56],0.95749613653875
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51706,3934,0.97 [0.91-1.04],0.4700346107513689
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51709,3930,0.97 [0.91-1.04],0.4299892882827335
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47964,104,1.03 [0.66-1.61],0.8876047182903088
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,51389,2433,0.94 [0.86-1.03],0.1929138139417984
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42850,3183,1.39 [1.29-1.49],3.137083562511213e-19
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,52059,456,1.93 [1.64-2.27],2.9623891458482213e-15
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,50157,167,1.88 [1.42-2.47],8.558636118693356e-06
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,49165,209,1.20 [0.89-1.61],0.224550187973462
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,49241,285,0.98 [0.75-1.28],0.8890125277605986
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",40006,339,1.14 [0.90-1.45],0.2788204030464011
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47394,311,2.00 [1.64-2.43],5.551006177973995e-12
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4281,174,1.84 [1.45-2.35],7.420183689707415e-07
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4556,506,1.25 [1.06-1.49],0.0097390953277445
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,47210,127,2.99 [2.34-3.81],8.637475722460148e-19
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4218,114,1.81 [1.32-2.49],0.0002298326778663
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50792,3709,1.50 [1.41-1.60],1.9614186774249664e-34
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,50699,709,1.23 [1.05-1.44],0.0118132992523022
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,47472,739,1.38 [1.18-1.61],4.082548350341264e-05
CLSTN2,Calsyntenin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,41216,1549,1.38 [1.25-1.53],1.004987688119363e-09
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51858,488,1.12 [0.92-1.37],0.2468240303393196
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49809,328,0.85 [0.65-1.10],0.2143456805169032
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,47572,2405,1.04 [0.95-1.14],0.4057486831929084
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49964,483,0.98 [0.80-1.21],0.8586611439761969
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,49601,120,1.96 [1.42-2.70],3.566954462167314e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49885,404,1.61 [1.33-1.95],8.809617708705893e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,32310,3852,1.45 [1.35-1.54],3.1814173036004286e-28
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,AV-block,43887,879,1.52 [1.33-1.74],7.276617895734151e-10
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51965,853,1.19 [1.03-1.38],0.017393164592953
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiac arrest,28841,383,1.84 [1.52-2.22],2.405167548474589e-10
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,43352,344,1.79 [1.47-2.18],1.0200706295172669e-08
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",43202,194,1.88 [1.45-2.43],1.5306832999708733e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,52081,104,1.39 [0.94-2.06],0.1009181489216816
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,45134,2126,1.53 [1.41-1.67],9.149029144919299e-23
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,49325,4194,1.16 [1.08-1.24],1.38679953461011e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,45455,15262,1.10 [1.06-1.14],1.0916771856462328e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,49295,526,1.15 [0.95-1.38],0.1608766882647391
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Endocarditis,43158,150,1.92 [1.44-2.56],8.892188838386321e-06
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",51672,2222,1.73 [1.60-1.87],6.396173733461024e-43
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertension,47299,13099,1.08 [1.04-1.12],0.0001472522353724
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",47336,13136,1.08 [1.04-1.12],0.0001964325546439
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",51737,155,4.87 [4.14-5.72],1.3124022851323587e-81
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34553,353,2.62 [2.23-3.07],1.947759711475176e-32
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34477,277,1.81 [1.45-2.25],1.1092800936439576e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Hypotension,51792,2376,1.30 [1.19-1.42],1.6058357294013559e-09
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,50226,213,1.25 [0.93-1.67],0.1374669521404405
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49664,4497,1.13 [1.06-1.20],0.0002838539962587
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",51324,1126,1.28 [1.13-1.45],8.798161481765689e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43736,728,1.60 [1.38-1.85],1.6036409230974958e-10
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,51120,1691,1.15 [1.04-1.28],0.0068931704363018
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46595,1428,1.18 [1.05-1.33],0.0041144089078748
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51896,315,0.97 [0.76-1.26],0.8390066207428931
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",52026,621,1.19 [1.00-1.41],0.0488904998370294
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Oesophageal varices,48876,107,4.63 [3.77-5.67],2.7971853664703204e-49
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other aneurysm,49640,159,1.32 [0.95-1.84],0.0957447850886689
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,43861,853,1.45 [1.27-1.67],1.169496705485991e-07
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,49684,203,1.49 [1.13-1.96],0.0051001755219015
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49961,480,1.48 [1.23-1.77],2.144632805757876e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,43368,360,1.48 [1.20-1.83],0.0002867910550681
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other disorders of veins,48966,197,1.73 [1.33-2.26],4.090345939503609e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48867,98,1.91 [1.33-2.75],0.0005019780269557
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,49196,131,1.34 [0.94-1.92],0.1053578292775871
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,49045,276,1.51 [1.19-1.90],0.0005426372432548
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,45097,2089,1.56 [1.43-1.70],6.905999975897169e-25
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,49526,110,4.03 [3.26-4.99],1.1388217504058791e-37
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,50573,1092,1.28 [1.12-1.45],0.0001660400949016
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50840,695,2.09 [1.84-2.37],8.85530560564948e-30
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",50302,1237,1.20 [1.06-1.36],0.0037494206358625
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,29142,684,1.75 [1.51-2.02],3.4143309459609136e-14
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,50234,816,1.64 [1.44-1.87],2.1760145471331409e-13
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),49458,689,1.16 [0.98-1.37],0.0839724085263154
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,51108,963,1.12 [0.98-1.29],0.106350755909132
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,51944,1323,1.61 [1.45-1.79],3.591545719386603e-19
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43711,703,1.62 [1.41-1.88],4.8550943212217165e-11
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50829,684,2.08 [1.83-2.37],4.0334801026210506e-29
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,49454,389,1.47 [1.20-1.80],0.0001567412899216
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",51301,1288,1.28 [1.14-1.44],3.401829318781643e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",51259,1365,1.29 [1.15-1.44],1.21858145284288e-05
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,50168,119,1.18 [0.79-1.75],0.4099642569148847
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,49642,162,1.32 [0.95-1.83],0.0963858398413755
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50673,475,1.19 [0.98-1.45],0.0866565715927135
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49952,523,1.00 [0.82-1.21],0.990111523834028
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Varicose veins,49622,853,1.53 [1.33-1.74],6.16571954308974e-10
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,49511,173,1.18 [0.85-1.64],0.3157490192251201
CLSTN2,Calsyntenin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,51627,1511,1.11 [0.99-1.24],0.0649393914058011
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51840,723,1.68 [1.46-1.93],1.821044074490672e-13
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",45560,2874,0.95 [0.88-1.04],0.2752035463913755
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Any mental disorder,50761,8075,1.07 [1.02-1.12],0.0106715407978473
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51745,856,1.54 [1.35-1.76],1.1442300798641216e-10
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45890,3204,0.94 [0.87-1.02],0.148212801598416
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42866,180,1.23 [0.89-1.69],0.2065072255467831
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Smoking dependency,51013,2765,1.18 [1.09-1.29],7.504158894132488e-05
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45978,3292,1.25 [1.16-1.34],7.986103936771409e-09
CLSTN2,Calsyntenin-2,Chapter V Mental and behavioural disorders,Vascular dementia,51059,256,1.51 [1.18-1.93],0.0010329341961543
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Alzheimer disease,52083,662,1.17 [0.99-1.38],0.0740549033677646
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",35094,117,1.27 [0.86-1.89],0.228819253381905
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Bell's palsy,48480,166,1.49 [1.10-2.03],0.0098219568094225
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,49308,994,0.98 [0.85-1.13],0.737947540191083
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral cysts,51261,463,1.33 [1.10-1.61],0.0034439295218247
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51923,650,1.10 [0.92-1.30],0.2883709046641518
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,51077,99,1.06 [0.68-1.65],0.7995361554386423
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,52050,120,1.23 [0.84-1.80],0.2871152225615759
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50946,148,1.27 [0.90-1.79],0.1797201202158903
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Epilepsy,48916,576,1.15 [0.96-1.38],0.1277197289908556
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,51110,2770,1.02 [0.94-1.11],0.634499502575127
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51998,1217,0.97 [0.86-1.11],0.69749104502027
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50878,5196,1.16 [1.09-1.23],1.5040576002795603e-06
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Generalized epilepsy,51313,108,1.82 [1.28-2.59],0.0007822629863669
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hemiplegia,51781,508,1.16 [0.96-1.40],0.1338287068214784
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Hydrocephalus,50921,123,1.29 [0.88-1.88],0.1913252871660563
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,52046,139,1.17 [0.81-1.69],0.3907622797019574
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,48465,151,0.80 [0.54-1.17],0.2442761847574805
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,48476,162,1.00 [0.71-1.42],0.9848211901415737
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Memory loss,50766,219,1.08 [0.80-1.45],0.6076448143358533
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Migraine,49067,727,0.80 [0.67-0.95],0.0121942627357321
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51941,653,0.77 [0.64-0.93],0.0069971197277778
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Motor neuron disease,35292,275,1.00 [0.76-1.32],0.985886976355035
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51745,210,0.70 [0.50-0.98],0.0357367667305414
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50732,2418,0.99 [0.91-1.09],0.8738485650954559
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Neurological diseases,49090,7603,1.05 [1.00-1.10],0.0759105183578651
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,51382,404,1.10 [0.89-1.37],0.3819466480925564
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",49146,832,0.94 [0.80-1.10],0.4328041679493966
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",51933,600,1.61 [1.38-1.87],1.2838929145898963e-09
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,41414,1301,1.10 [0.97-1.24],0.1440702302539587
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50948,150,0.94 [0.65-1.37],0.7590708415512749
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,51079,281,0.99 [0.76-1.29],0.933451399274777
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,51111,330,1.20 [0.95-1.51],0.1303360187919621
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,48509,195,1.46 [1.10-1.94],0.0091473381399206
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other headache syndromes,48456,116,0.80 [0.52-1.25],0.3281021483141344
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,51841,1043,1.09 [0.95-1.25],0.2224939153242643
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,49470,1130,0.98 [0.86-1.12],0.7655558638586739
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Parkinson's disease,52037,862,0.90 [0.77-1.05],0.1756469080013916
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50908,110,0.79 [0.50-1.23],0.2978294354121429
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Restless leg syndrome,52083,157,0.93 [0.65-1.34],0.7029293488904222
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,51593,972,0.99 [0.86-1.14],0.8605279433818097
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,51432,99,1.21 [0.79-1.86],0.3732125721182112
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,52056,330,1.03 [0.80-1.31],0.8266533216646453
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,48418,104,0.96 [0.61-1.50],0.852735357435733
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,52083,669,1.17 [0.99-1.38],0.0726341131772835
CLSTN2,Calsyntenin-2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50983,249,1.49 [1.16-1.91],0.0019398477081603
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,50930,198,1.16 [0.85-1.58],0.353170080367547
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,51257,798,0.95 [0.81-1.12],0.5489786966773235
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51734,468,1.63 [1.37-1.93],3.325305413332218e-08
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,50064,107,1.22 [0.81-1.83],0.3459573362947014
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,50073,116,1.19 [0.80-1.77],0.37908251335303
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51865,104,0.87 [0.55-1.37],0.5578015684570332
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,51556,295,0.94 [0.72-1.23],0.6471268714298307
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4228,121,1.76 [1.29-2.39],0.000333175664117
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5120,204,1.83 [1.48-2.27],4.163396801689956e-08
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50921,189,0.90 [0.64-1.25],0.5199334309266203
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,51648,2084,1.25 [1.14-1.38],1.5087393640434273e-06
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",51346,1389,1.04 [0.92-1.17],0.5636153384979911
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,50406,449,0.84 [0.67-1.05],0.1358052855677935
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51913,1454,1.02 [0.91-1.15],0.7373198848113829
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,52064,137,0.74 [0.49-1.12],0.1537692161962668
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,51764,1305,0.97 [0.86-1.10],0.6521447445499016
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51997,736,1.00 [0.85-1.19],0.9585350334126644
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51896,361,1.14 [0.91-1.44],0.2650513620996781
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,50077,120,1.03 [0.69-1.55],0.8679054064048739
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,50089,132,0.63 [0.41-0.98],0.0388030692573403
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,50067,110,0.77 [0.49-1.22],0.2733543961684982
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51899,1425,1.13 [1.01-1.27],0.040622686261091
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50846,372,0.94 [0.74-1.20],0.6277333177439746
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,50559,100,0.98 [0.62-1.54],0.9226097067608204
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,51462,201,1.20 [0.88-1.62],0.2465673796413545
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51811,550,0.97 [0.80-1.18],0.7421487835157188
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50846,387,0.98 [0.78-1.24],0.8909649023788163
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51757,222,1.05 [0.78-1.43],0.7300117446862835
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,51423,949,1.13 [0.98-1.30],0.1046137469600737
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,51016,284,1.00 [0.77-1.30],0.999188726903516
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48860,4376,1.06 [0.99-1.13],0.1242713206830411
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,51739,478,0.97 [0.79-1.20],0.800988413109989
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,52042,305,1.27 [1.00-1.62],0.048783151674904
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50779,822,1.05 [0.90-1.22],0.5695350636987737
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,51390,129,1.08 [0.73-1.60],0.6839200342170386
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,52038,111,0.81 [0.52-1.27],0.3650068934215513
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,50128,171,1.30 [0.95-1.79],0.1063889692896144
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,50257,300,0.96 [0.74-1.25],0.7552678835514934
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49800,236,1.19 [0.90-1.57],0.2353127002819898
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,50583,124,1.26 [0.86-1.83],0.2359551718837292
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",49691,127,1.23 [0.85-1.80],0.2738262991995697
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,50650,176,1.24 [0.90-1.72],0.1840689175948039
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50868,394,1.20 [0.97-1.50],0.0940286134771111
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,50212,255,1.32 [1.02-1.71],0.0346386384861001
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49786,222,0.84 [0.61-1.15],0.2816724728238606
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,49735,171,1.39 [1.02-1.90],0.039734242276774
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,48111,3627,1.12 [1.04-1.20],0.0026601493843579
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,50101,144,0.89 [0.60-1.31],0.5414358515594495
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,51562,830,1.01 [0.87-1.19],0.8575480153683094
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50851,119,1.25 [0.85-1.85],0.2558742341346997
CLSTN2,Calsyntenin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),51074,342,1.26 [1.01-1.58],0.0416056909715268
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,51657,174,1.21 [0.87-1.68],0.2511731431474597
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51994,241,1.05 [0.79-1.40],0.729855569191298
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51819,260,1.18 [0.90-1.54],0.2238183406888151
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,51602,119,0.97 [0.64-1.47],0.8754025801626588
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,51609,126,0.96 [0.64-1.43],0.8343688731337395
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51887,1815,0.98 [0.88-1.09],0.6985499950391583
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,51371,1299,1.03 [0.91-1.16],0.6640083480102561
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,50328,256,0.71 [0.52-0.96],0.0264497483206029
CLSTN2,Calsyntenin-2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,50246,174,1.32 [0.97-1.80],0.0818280213477422
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute pharyngitis,51593,151,1.09 [0.76-1.55],0.6469457203465077
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51870,428,1.11 [0.90-1.38],0.3096593170502987
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,51569,127,1.18 [0.81-1.72],0.3946877220966516
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,All influenza,48014,239,1.49 [1.16-1.92],0.0021027955090226
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),48009,234,1.48 [1.14-1.92],0.002839011960733
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35692,236,1.25 [0.94-1.65],0.1199410189607417
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Allergic rhinitis,51816,561,0.89 [0.73-1.08],0.2416279576953208
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",38479,3568,1.10 [1.02-1.19],0.0091380931350335
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38970,3514,1.08 [1.01-1.17],0.0365224461215593
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),51265,279,1.41 [1.10-1.79],0.0060163516985705
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47939,164,1.29 [0.93-1.78],0.1314817051078949
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Bronchiectasis,45142,708,1.24 [1.05-1.46],0.0090233339360501
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",44551,117,0.84 [0.54-1.30],0.4374852475762606
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,50044,5610,1.12 [1.06-1.19],0.00010264517951
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",49320,142,0.86 [0.58-1.28],0.4597023442930215
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,49491,313,1.12 [0.88-1.44],0.3484711562258344
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51680,2394,1.28 [1.17-1.39],1.8728681452674232e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,49394,216,0.75 [0.54-1.03],0.0755671358232234
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47926,10602,1.14 [1.09-1.19],1.3207401506736679e-09
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49909,731,0.94 [0.80-1.11],0.4763401691585193
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Early onset COPD,49921,635,1.37 [1.17-1.60],0.0001134078693574
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Emphysema,45067,633,1.24 [1.05-1.47],0.0120207713925951
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49473,578,1.14 [0.95-1.37],0.1522542318491474
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,51636,3861,1.32 [1.23-1.41],3.0240631093608216e-16
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,49542,647,1.22 [1.03-1.44],0.018960896974806
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Later onset COPD,50068,1759,1.27 [1.15-1.40],4.051039909040664e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,52058,662,1.11 [0.93-1.31],0.2401204834080645
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Nasal polyp,49395,217,1.17 [0.88-1.56],0.2921402670012318
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,51581,1954,1.31 [1.19-1.43],1.884075514170169e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,51607,4004,1.36 [1.28-1.45],6.5561743662590756e-21
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50855,1677,0.94 [0.84-1.06],0.3138648392772177
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other pleural conditions,47704,101,1.52 [1.03-2.24],0.0337387026576888
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51907,807,1.37 [1.19-1.58],1.1883425268828268e-05
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51868,2607,1.30 [1.20-1.41],1.684128636130479e-10
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural effusion,49605,2002,1.58 [1.45-1.72],1.3339542822078536e-25
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pleural plaque,47914,311,1.36 [1.08-1.71],0.0100079625882236
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",51128,3353,1.35 [1.26-1.45],4.7086056318219335e-17
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,51926,530,1.18 [0.98-1.42],0.0817378624119901
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pneumothorax,47839,236,1.45 [1.12-1.89],0.0048368444066596
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pollen allergy,52035,478,0.86 [0.70-1.07],0.1711742079094192
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Pulmonary oedema,51232,132,2.02 [1.50-2.72],3.6948460655746414e-06
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35565,109,1.58 [1.08-2.32],0.0177236727847803
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,51538,1911,1.31 [1.19-1.44],1.4279209469187266e-08
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,49741,563,0.89 [0.73-1.08],0.2407553872882488
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Viral pneumonia,48278,503,1.03 [0.84-1.25],0.7791471322236636
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",51293,414,0.97 [0.78-1.21],0.7755649278183308
CLSTN2,Calsyntenin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,24025,225,1.34 [1.01-1.79],0.0452229724311099
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36784,128,0.94 [0.63-1.41],0.7677341661102189
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,51759,294,0.75 [0.57-0.99],0.0442696084762101
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute gastritis,39179,179,1.12 [0.81-1.56],0.4969703723128623
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,48360,369,1.07 [0.85-1.35],0.5460613999696624
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Acute peritonitis,51133,188,2.09 [1.64-2.66],2.5040098249279744e-09
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,50281,150,4.19 [3.48-5.05],1.69088258616729e-51
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Barrett oesophagus,39879,879,1.07 [0.92-1.24],0.3700383517045793
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",48193,202,1.13 [0.83-1.53],0.4411372355765736
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",51237,202,1.12 [0.83-1.52],0.4510639930253752
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholecystitis,48402,411,0.72 [0.57-0.92],0.0074568053311013
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,49995,2004,0.89 [0.80-0.98],0.0200659076908501
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,39618,618,1.16 [0.97-1.38],0.1039293932226424
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,48092,101,1.43 [0.96-2.13],0.0747711472924462
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",51790,208,4.54 [3.91-5.27],5.923930792545645e-88
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Coeliac disease,48844,249,0.65 [0.48-0.89],0.0073537095495095
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Collagenous colitis,48701,166,1.46 [1.07-2.00],0.0160330796946573
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51775,373,1.00 [0.79-1.26],0.9931449221451176
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Constipation,51565,3376,1.12 [1.04-1.21],0.0024528167361832
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn disease,48722,187,1.21 [0.89-1.65],0.2327035295407269
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",51371,137,1.19 [0.83-1.71],0.3471844376660128
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48711,176,1.40 [1.03-1.90],0.0303589515390664
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Dental caries,50586,461,1.14 [0.93-1.39],0.2022837206560647
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46736,4476,0.89 [0.83-0.95],0.0006250850497445
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,51834,369,0.65 [0.50-0.84],0.000836108626908
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of liver,51837,1706,1.90 [1.74-2.07],1.7125770652180685e-48
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47715,8715,1.02 [0.97-1.07],0.4389016971961738
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",51242,1117,1.13 [0.99-1.28],0.0687497089121265
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51910,965,1.12 [0.98-1.29],0.1083467750954534
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,50357,232,1.06 [0.79-1.41],0.6970862211537898
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,50057,132,0.95 [0.64-1.42],0.8176418510460821
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,51455,2860,1.13 [1.05-1.23],0.0022289103788712
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diseases of tongue,50088,224,1.12 [0.83-1.50],0.4558751540697332
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50814,2823,0.96 [0.88-1.05],0.3542839793804155
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,43007,6351,0.96 [0.90-1.01],0.121273385321175
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,39401,401,1.48 [1.21-1.80],0.0001226089059326
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51914,322,1.36 [1.09-1.71],0.0069617732180108
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51903,112,0.84 [0.54-1.31],0.4374805731841615
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,50384,253,4.06 [3.52-4.69],4.086531759298296e-81
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36951,295,1.08 [0.84-1.40],0.555186639945096
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,40106,1106,0.87 [0.75-1.00],0.0472596638492065
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,39722,722,1.19 [1.01-1.40],0.0353447900289592
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,44046,5046,0.87 [0.82-0.93],3.9233991050119135e-05
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,40081,1081,1.23 [1.08-1.40],0.0019831508382976
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,40324,16717,0.99 [0.95-1.02],0.4633092961836458
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,GI-bleeding,50939,2344,1.16 [1.06-1.27],0.0009506108441502
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,50234,109,1.03 [0.68-1.58],0.880933854368001
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38621,2540,0.99 [0.91-1.08],0.8482257087095971
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",50259,128,3.75 [3.02-4.64],2.064261786919311e-33
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Hernia,48791,6531,0.90 [0.85-0.96],0.0004714147684097
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impacted teeth,51917,104,0.82 [0.52-1.31],0.411682663953593
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Impaction of intestines,36769,113,0.97 [0.63-1.49],0.8822904168077716
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,44079,1819,0.95 [0.85-1.05],0.3169235138892003
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",42468,208,1.19 [0.89-1.60],0.2339156112405915
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36852,196,1.28 [0.95-1.73],0.1018797016619791
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48883,288,0.71 [0.53-0.94],0.0180517817467996
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37768,1112,0.99 [0.86-1.13],0.8647591821324585
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,52026,747,1.63 [1.42-1.86],2.359082059033033e-12
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,50055,1520,1.10 [0.98-1.23],0.1068515699611958
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50559,2024,1.10 [1.00-1.21],0.0551491278605521
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,39380,380,1.06 [0.84-1.33],0.6324677726038135
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oesophagitis,40215,1215,1.11 [0.98-1.26],0.1019927305710716
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51983,276,1.03 [0.79-1.35],0.8045373767082702
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,42399,139,0.93 [0.64-1.37],0.7309608703597072
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,39401,2745,1.02 [0.94-1.11],0.5926775601566645
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48557,566,0.96 [0.79-1.16],0.6924049196567141
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,48310,319,0.77 [0.59-1.01],0.059404923213433
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,40168,3512,1.13 [1.05-1.21],0.001207648783398
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,48027,11371,1.01 [0.96-1.05],0.7716261297676064
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,50042,416,0.93 [0.74-1.17],0.5352140273099455
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,51528,1397,1.92 [1.75-2.12],5.300959842034159e-42
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,40340,1340,1.12 [0.99-1.26],0.0690506458677995
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,48294,303,1.24 [0.97-1.59],0.080844145751529
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51773,828,0.99 [0.85-1.16],0.8844998886000285
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40918,1918,1.17 [1.06-1.30],0.0014984718070935
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50970,2375,1.16 [1.06-1.26],0.0011826696963688
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,50502,377,1.11 [0.89-1.39],0.3587487175601745
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,40126,3470,1.12 [1.04-1.20],0.0040262692934755
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),43050,4050,1.11 [1.04-1.19],0.0027536351284516
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,50330,199,3.05 [2.52-3.69],3.9558743587468274e-30
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,50312,1777,1.12 [1.01-1.24],0.0310607638126052
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",37348,692,1.11 [0.94-1.31],0.229067413802734
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51883,131,0.88 [0.58-1.31],0.5214901796426281
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37643,987,1.12 [0.97-1.29],0.1151305612147211
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48896,301,1.40 [1.11-1.77],0.0042581458184775
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,52062,115,0.96 [0.63-1.47],0.8590286740453837
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,50136,238,0.91 [0.67-1.23],0.5313748429648126
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Toxic colitis,48650,115,0.90 [0.58-1.38],0.6171756277369559
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39535,535,0.99 [0.81-1.20],0.8952565000246833
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,48858,323,0.99 [0.77-1.27],0.9307408426328224
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48803,268,1.01 [0.77-1.33],0.9478478810489874
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,42807,547,1.11 [0.93-1.33],0.2569224638863564
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,37009,353,1.32 [1.06-1.65],0.0126402716680417
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Ventral hernia,42786,526,0.99 [0.82-1.20],0.9247028814893974
CLSTN2,Calsyntenin-2,Chapter XI Diseases of the digestive system,Volvulus,36816,160,1.02 [0.72-1.46],0.9052856163639956
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51917,598,1.11 [0.93-1.33],0.2575379100192542
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,51430,148,1.18 [0.84-1.67],0.3386614062804668
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47953,323,0.96 [0.74-1.24],0.7602175605027041
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50797,1415,1.46 [1.32-1.62],4.524882201370991e-13
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49734,352,1.11 [0.88-1.40],0.3985051996804206
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,48451,821,1.49 [1.29-1.71],2.247665232145845e-08
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,51463,557,1.19 [1.00-1.43],0.0566050441198944
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51879,973,1.18 [1.03-1.36],0.0157616812852298
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,51003,97,1.52 [1.03-2.25],0.0338023169130014
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48941,6463,1.18 [1.12-1.24],2.0100797669203067e-09
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,51170,903,0.97 [0.83-1.12],0.6473520077121867
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50902,635,0.97 [0.81-1.16],0.7335746433993195
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,51294,1912,1.37 [1.25-1.50],1.2265384186347871e-11
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",52049,110,0.92 [0.60-1.43],0.7202409531678413
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47744,114,0.39 [0.24-0.62],8.935210027392105e-05
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,50373,106,0.84 [0.53-1.31],0.4378106565114853
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,51443,537,1.22 [1.01-1.46],0.0342799994756826
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48543,913,1.14 [0.99-1.32],0.068036576437707
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47758,128,1.11 [0.75-1.64],0.6062601177611221
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51909,168,1.36 [0.99-1.85],0.054071913743052
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,49763,381,1.51 [1.24-1.84],4.548966627821265e-05
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51673,391,1.02 [0.82-1.28],0.832393796743159
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,51036,130,0.96 [0.64-1.43],0.8378062893943296
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47766,136,1.29 [0.90-1.85],0.1695673073846483
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50915,3285,1.25 [1.16-1.35],2.1928736429698404e-09
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48620,990,1.21 [1.05-1.38],0.0068238284000784
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47766,136,1.06 [0.72-1.56],0.7550129523830063
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51903,621,0.93 [0.77-1.11],0.4297540307501291
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,51045,139,1.12 [0.78-1.62],0.5426455210491616
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51791,509,0.94 [0.77-1.14],0.5154463663160108
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51974,655,1.11 [0.94-1.32],0.2226642221771755
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47885,255,0.92 [0.69-1.23],0.5846396432112955
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,48169,539,1.14 [0.95-1.38],0.1669622791301425
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51952,633,1.12 [0.94-1.33],0.2065642770474209
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",48109,479,2.05 [1.76-2.39],7.245090347543031e-20
CLSTN2,Calsyntenin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,52022,281,1.30 [1.02-1.66],0.0344630375233766
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44678,222,0.97 [0.72-1.31],0.8434099997894702
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,47402,11373,1.01 [0.97-1.05],0.6821630087106438
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,44550,8521,0.98 [0.93-1.03],0.3697961111145849
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,44607,151,0.66 [0.45-0.99],0.0434551316391536
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,45152,309,0.97 [0.75-1.26],0.8259775533509929
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,45204,361,1.04 [0.82-1.32],0.7190929650095363
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,51581,185,1.12 [0.81-1.54],0.4906865920948841
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",45043,200,1.16 [0.85-1.59],0.3429166613631524
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,38317,2288,0.98 [0.89-1.08],0.6540080796100296
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51810,381,0.86 [0.67-1.09],0.2000043347387529
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45740,897,0.87 [0.75-1.02],0.0887666396779856
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,44025,14638,1.01 [0.97-1.05],0.576788278726547
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,48096,236,1.12 [0.85-1.49],0.4206628905409176
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44761,305,1.05 [0.81-1.35],0.7297269241232063
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45602,1146,0.93 [0.81-1.06],0.2878576406178376
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,50205,5362,1.01 [0.95-1.08],0.7273921034410794
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,45004,548,1.01 [0.83-1.23],0.9038775422991866
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44898,442,0.72 [0.57-0.91],0.0049690075945317
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44725,269,0.94 [0.71-1.25],0.6912965291039797
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50790,142,1.44 [1.02-2.02],0.0359887691681001
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,39438,3409,0.96 [0.89-1.04],0.3404649049732841
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,37251,1222,1.36 [1.21-1.52],1.0661923612618422e-07
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",51931,1205,1.34 [1.19-1.50],7.86209642224686e-07
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,36181,152,0.84 [0.57-1.24],0.377283173776602
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36696,667,0.83 [0.69-1.00],0.0543489529065307
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,45071,615,0.88 [0.73-1.06],0.1750511671806088
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,37318,1289,0.88 [0.77-1.00],0.0569938162879442
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44955,112,1.28 [0.85-1.91],0.2315154858202523
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,46108,1265,0.93 [0.82-1.06],0.3059611153741194
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,45456,613,0.99 [0.83-1.19],0.9278694754035034
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,37233,1204,0.87 [0.76-1.00],0.0422487201928037
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,44618,162,1.26 [0.91-1.75],0.1687107419275312
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",44581,125,0.70 [0.45-1.08],0.105532565598414
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,48004,144,1.87 [1.40-2.50],2.302120590090209e-05
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,51301,3441,1.10 [1.02-1.19],0.0105738686530417
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,50115,2255,1.15 [1.05-1.27],0.0023911747699715
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51795,909,1.03 [0.89-1.19],0.6989265006904928
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,41044,5015,1.00 [0.93-1.06],0.8802680718306723
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,36154,125,0.83 [0.55-1.26],0.3852736597864368
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,44643,187,1.07 [0.77-1.48],0.6897892180127028
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,36128,99,1.56 [1.06-2.30],0.0225937087224016
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),36280,251,0.85 [0.63-1.14],0.2809594210306172
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,48346,486,0.91 [0.74-1.12],0.3861129275715959
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,48624,764,0.89 [0.75-1.05],0.178464603842826
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,52018,204,0.95 [0.69-1.31],0.7649803431849177
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",48477,3634,1.00 [0.93-1.08],0.992556755738795
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44660,204,0.90 [0.65-1.24],0.50381554448624
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),36308,279,0.88 [0.66-1.17],0.3710490419961436
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,46301,1458,0.99 [0.88-1.11],0.8333475411919196
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,40373,4344,0.97 [0.90-1.04],0.3449571734669956
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50839,191,1.31 [0.97-1.77],0.0795386558163418
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,52046,141,1.16 [0.81-1.66],0.4149491180799477
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44621,165,1.03 [0.73-1.45],0.8686834539923696
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46970,2514,1.06 [0.97-1.16],0.1900490570709845
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,44637,181,1.22 [0.89-1.67],0.2190790362941675
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,39300,3271,0.99 [0.92-1.08],0.8933121673319476
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,48085,225,0.70 [0.50-0.96],0.0278845221942869
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,44564,108,0.69 [0.43-1.10],0.1229358451399841
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,45164,321,0.78 [0.60-1.02],0.0737702706351516
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,45570,1114,1.20 [1.06-1.36],0.0052366735169802
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,51363,715,0.82 [0.69-0.98],0.0323582014799641
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45994,1151,1.08 [0.95-1.23],0.2556770269353611
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51819,883,1.05 [0.90-1.22],0.5468337133238554
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,52039,109,1.02 [0.66-1.57],0.9279756992699748
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44841,385,0.97 [0.77-1.22],0.8037741385460061
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,41231,1525,1.10 [0.98-1.23],0.1111070331869953
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,45630,1174,1.04 [0.92-1.19],0.5227507772722333
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44913,457,1.01 [0.82-1.25],0.9256998497057668
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",36138,109,0.99 [0.64-1.53],0.9482595678604184
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,41041,5012,1.09 [1.02-1.16],0.0083269344547085
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,37347,1318,0.93 [0.82-1.06],0.2914431876808835
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,51119,471,0.94 [0.76-1.16],0.5668543024394233
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",51949,135,1.12 [0.77-1.63],0.5610241540936279
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",47711,103,1.05 [0.69-1.61],0.818894953999476
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,36173,144,1.16 [0.81-1.66],0.4039402529127093
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,45047,204,0.83 [0.60-1.16],0.2759757748427915
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36950,921,1.03 [0.89-1.19],0.7287445670155258
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,45075,619,0.93 [0.77-1.12],0.4383071597649132
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,45356,513,0.97 [0.79-1.18],0.7487894329912749
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,45222,379,0.92 [0.73-1.18],0.5233723786612674
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40719,118,0.79 [0.51-1.23],0.2894037982718336
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",52047,117,0.92 [0.60-1.41],0.6983143469058568
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,45647,1191,0.97 [0.85-1.10],0.6101399119640795
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],50830,182,0.61 [0.42-0.87],0.0073690521432745
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,49644,5188,1.03 [0.97-1.09],0.3809087509631575
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44722,266,0.86 [0.64-1.14],0.293261435645734
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45939,1096,1.09 [0.95-1.24],0.2222082016834985
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,49253,474,0.84 [0.68-1.04],0.1094147585099169
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,45259,416,0.77 [0.61-0.98],0.0325077299469374
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47980,3137,1.00 [0.92-1.08],0.9730560135117308
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46902,2059,0.96 [0.87-1.07],0.4672115104832748
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],44565,109,1.26 [0.84-1.88],0.2645235383406741
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50916,268,0.62 [0.46-0.83],0.0016189065596718
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44785,329,1.01 [0.79-1.29],0.9656328156902112
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,44609,153,0.78 [0.53-1.15],0.2046839856022825
CLSTN2,Calsyntenin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),36145,116,1.01 [0.66-1.54],0.9720004060679072
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49970,3172,1.57 [1.47-1.68],1.802665140615348e-38
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21017,104,0.95 [0.61-1.48],0.8213037774531833
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27363,112,1.11 [0.74-1.69],0.608884590884843
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,51436,654,1.23 [1.05-1.45],0.0113696626842883
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50950,168,0.78 [0.54-1.13],0.1866797340967447
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49875,3077,1.48 [1.37-1.59],2.1486802906322983e-26
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,51652,167,1.95 [1.51-2.52],4.126931227952542e-07
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,51586,607,1.12 [0.94-1.33],0.2243788316600674
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,45874,470,1.02 [0.83-1.26],0.851017828453116
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Dialysis,46958,160,1.79 [1.34-2.39],8.160516445462761e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22714,3350,1.05 [0.97-1.13],0.2007690404468813
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27594,343,0.96 [0.75-1.22],0.715148841358977
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,21098,185,0.86 [0.61-1.21],0.381233889500834
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21318,405,0.70 [0.55-0.88],0.0019980682368602
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21942,1029,0.69 [0.59-0.80],1.9958475058567267e-06
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,43467,10815,1.10 [1.05-1.15],1.3070261000117576e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,51654,169,1.82 [1.38-2.39],2.074189567200237e-05
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19574,210,1.16 [0.87-1.56],0.3170504960293662
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46778,592,1.18 [0.99-1.41],0.0706775151071975
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,22000,2636,1.06 [0.97-1.15],0.1816959163669551
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27514,406,1.02 [0.82-1.28],0.8338290717367738
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19598,234,1.08 [0.82-1.44],0.5821748839931589
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27599,131,0.94 [0.63-1.39],0.7386651047808263
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21224,311,0.62 [0.47-0.80],0.0003443993551785
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45564,160,0.93 [0.64-1.33],0.6815225050607541
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23419,2506,0.86 [0.78-0.94],0.001447191396279
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19475,111,1.02 [0.67-1.55],0.9377179140627098
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21056,143,0.81 [0.54-1.19],0.2797857552569316
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",52057,128,0.92 [0.62-1.38],0.6971895465960147
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",52066,133,1.04 [0.71-1.53],0.846735980216819
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49972,4568,1.10 [1.03-1.17],0.0038272575962621
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46850,1446,1.00 [0.89-1.13],0.966463498545342
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27371,120,1.01 [0.67-1.53],0.9436983524102062
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51943,964,1.05 [0.91-1.21],0.4796956955308555
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19677,313,1.20 [0.95-1.52],0.1315429200670929
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19645,281,1.03 [0.79-1.34],0.8347865352186546
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19597,233,0.78 [0.57-1.06],0.1160262873622182
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,52004,142,0.71 [0.47-1.07],0.0984705076481217
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48920,3516,1.13 [1.05-1.22],0.0009122251239543
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27317,209,0.98 [0.71-1.33],0.8757300857775352
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21071,158,0.97 [0.67-1.39],0.8550366061565369
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21290,377,0.82 [0.64-1.04],0.0991559332166032
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,21024,111,1.33 [0.89-1.97],0.1648765285980515
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21124,211,1.14 [0.84-1.54],0.3981397439581232
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46877,691,1.12 [0.94-1.32],0.1967903339057073
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,51298,319,0.94 [0.73-1.21],0.6419978551599071
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21227,314,0.98 [0.76-1.27],0.8959659921775177
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21022,109,0.45 [0.28-0.72],0.0007854512096897
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21573,660,0.94 [0.78-1.12],0.4668599357483042
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,21077,164,0.94 [0.65-1.35],0.7362805736924907
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21520,607,1.00 [0.83-1.20],0.969319930336356
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,51582,97,1.17 [0.76-1.81],0.4832002107012931
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19634,270,1.03 [0.79-1.34],0.8224782256525185
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51577,5391,1.37 [1.30-1.45],2.702262416253645e-29
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",46430,244,1.17 [0.89-1.55],0.2582218965618119
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,47061,263,2.08 [1.69-2.56],3.667563491875062e-12
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50895,113,0.74 [0.47-1.16],0.185579364502613
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45851,447,1.15 [0.94-1.42],0.1697648188904967
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51587,805,1.12 [0.96-1.30],0.160704442830841
CLSTN2,Calsyntenin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21057,144,1.42 [1.01-1.98],0.0415352101917121
